News

Freddie Mac Reports Stable Mortgage Rates as Market Evolves

Freddie Mac Reports Stable Mortgage Rates as Market Evolves

Freddie Mac Reports Stable Mortgage Rates

In the latest update, Freddie Mac has reported a steady average for the 30-year fixed-rate mortgage (FRM) at 6.58%. As homebuyers navigate the current market, this stability comes as they weigh their options cautiously.

Current Mortgage Rate Insights

According to Freddie Mac, the longstanding fixed-rate mortgage has shown resilience this week. Sam Khater, the Chief Economist at Freddie Mac, stated, “The 30-year fixed-rate mortgage remained flat this week.” He further mentioned, “Those looking to purchase homes are taking advantage of lower rates seen during the summer, although many potential buyers are pausing to see if rates will drop further.”

In-Depth Look at Mortgage Rates

As of the most recent report, the 30-year FRM held steady at 6.58%, a slight increase compared to last year when it averaged 6.46%. Additionally, the 15-year FRM showed a minor decline, averaging 5.69% compared to 5.71% the previous week and slightly higher than 5.62% from last year. These figures reveal trends that both buyers and industry experts keep a close watch on.

Understanding the PMMS

The Primary Mortgage Market Survey (PMMS), conducted by Freddie Mac, is an essential tool providing insight on conventional, fully amortizing home purchase loans. It predominantly focuses on borrowers putting 20% down and possessing excellent credit. This focus ensures the data reflects reliable lending practices, helping gauge market conditions effectively.

Freddie Mac's Role in the Housing Market

Freddie Mac is committed to making homes accessible and affordable across the nation. Since its inception in 1970, the organization has played a crucial role by adding liquidity and stability to the housing market, benefiting millions of families. Through various economic cycles, Freddie Mac has been instrumental in both facilitating home purchases and maintaining homeowner stability.

Consumer Resources and Support

Freddie Mac offers several resources and educational materials to support consumers during their homebuying journey. Whether it's understanding mortgage options or planning for payments, the organization's commitment remains strong in promoting financial literacy among consumers.

Frequently Asked Questions

What is the current average rate for a 30-year fixed mortgage?

The current average for a 30-year fixed-rate mortgage is 6.58% according to Freddie Mac.

How does the 15-year fixed-rate mortgage compare?

The 15-year fixed-rate mortgage is currently averaging 5.69%, showing a slight decrease from the previous week.

What is the focus of Freddie Mac's PMMS?

The PMMS focuses on conventional, fully amortizing home purchase loans, specifically aimed at borrowers with 20% down and excellent credit.

How long has Freddie Mac been in operation?

Freddie Mac has been operational since 1970, playing a significant role in the U.S. housing market.

What resources does Freddie Mac provide for consumers?

Freddie Mac provides a variety of resources, including educational materials and market updates to assist consumers in their home buying process.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Black Diamond Group Achieves Key Milestones in Q3 2024

Updated Category News Views 251

Black Diamond Group Reports Strong Q3 2024 Performance Black Diamond Group Limited, recognized for its space rental and workforce accommodation solutions, recently reported its operating and financial results for the third quarter of 2024. The company has shown remarkable resilience with a strong foundation, enabling it to adapt to changing market dynamics and maintain...

Continue Reading
Potential Unicredit and Commerzbank Merger Promises Stakeholder Gains

Updated Category News Views 194

Unicredit and Commerzbank Merger: A Possible Game Changer The potential merger between Italy's Unicredit and Germany's Commerzbank has certainly caught the attention of the banking industry. In a recent interview with Handelsblatt, Unicredit's CEO, Andrea Orcel, shared his perspective, suggesting that this merger could bring significant advantages for all parties...

Continue Reading
Future Trends and Growth of Wearable Cardiac Devices in Healthcare

Updated Category News Views 100

Unlocking the Future of Wearable Cardiac Devices In the rapidly evolving landscape of healthcare technology, wearable cardiac devices have emerged as game-changers. These devices, which include smartwatches and ECG patches, are not just sophisticated gadgets; they represent the forefront of health monitoring. Predictions suggest that the global market for wearable cardiac...

Continue Reading
Pivotal Research Starts Coverage of Alphabet and Meta Stocks

Updated Category News Views 75

Pivotal Research Initiates Coverage of Alphabet and Meta Pivotal Research Group has recently begun coverage of Alphabet Inc. (NASDAQ: GOOGL), renowned for being the parent company of Google, assigning it a Buy rating. This rating comes from the assessment of Alphabet's strong competitive stance and promising growth trajectory in cloud computing and artificial intelligence...

Continue Reading
Innovative Belt Design Enhances Comfort and Style for All

Updated Category News Views 130

Revolutionizing Belt Design for Enhanced Functionality Inventors are always looking for ways to improve everyday items, and the MAGNET BELT is a prime example of innovative thinking. One inventor recognized the frustrations that come with traditional belt designs and sought a solution. "I envisioned a better method to secure the end portion of a belt to stop it from...

Continue Reading